About Us
NuPathe is a privately-held specialty pharmaceutical company, located in Conshohocken, PA, just outside of Philadelphia. The Company was founded in 2005 by experienced pharmaceutical executives Jane Hollingsworth and Terri Sebree and is supported by leading healthcare venture capitalists.
NuPathe specializes in the development of therapeutic products for neurological and psychiatric diseases. NuPathe’s mission is to identify and address the needs of patients, their families, and health care professionals that are insufficiently met by current treatments. NuPathe accomplishes its mission by licensing or acquiring product that can have an immediate and significant impact on disease treatment and management.
The NuPathe team has a proven track record in the identification and development of novel therapeutics and is applying this expertise to build and develop a product portfolio of neuroscience-based products. Some of NuPathe’s accomplishments include:
